Can RWD and RWE encompass results obtained from the control arm of
contemporaneous medical trials?
AI Overview
"Yes, both Real-World Data (RWD) and Real-World Evidence (RWE) can indeed encompass results obtained from the control arms of contemporaneous medical trials. RWD, which is data collected from diverse sources outside of traditional clinical trials, can be used to form external control arms in clinical trials. RWE, the evidence derived from analyzing RWD, can then be used to compare outcomes between the treatment arm and this external control arm.
Here's a more detailed explanation:
1. Real-World Data (RWD) and External Control Arms:
Traditional Clinical Trials:
Typically, clinical trials involve a control group that receives a placebo or standard treatment, and an experimental group that receives the new treatment. These control groups are often established within the same trial.
External Control Arms:
In some cases, instead of using a control group within the trial, researchers might use data from an external source as a comparator. This external data can come from various RWD sources, such as:
Electronic Health Records (EHRs)
Medical Claims Data
Disease or product registries
Other sources like digital health technologies
Contemporary Trials:
An external control arm can be formed using RWD from a period contemporaneous with the trial's active treatment phase. This means the RWD is collected at the same time as the experimental group is being treated within the trial.
2. Real-World Evidence (RWE) and Comparison:
Analysis of RWD:
.
RWE is the evidence generated by analyzing RWD. This analysis can involve comparing the outcomes of the experimental group in the trial with the outcomes observed in the external control arm derived from RWD.
Informing Decisions:
.
By comparing the two, researchers can assess the effectiveness of the new treatment in the trial against a real-world population, which may have different characteristics than the trial's population. This can help to understand how the treatment might perform in broader clinical practice.
3. Examples:
Oncology Trials:
.
In oncology, single-arm trials (trials without a control arm) are common. Researchers may use RWD to establish an external control arm to evaluate the effectiveness of a new cancer treatment.
Drug Development:
.
RWE derived from external control arms can be used to support regulatory submissions for new drug approvals or to expand the indications of existing drugs.
4. Key Considerations:
Data Quality:
It's crucial to carefully assess the quality and reliability of the RWD used to form external control arms.
Bias:
Researchers need to address potential biases that might exist in RWD, such as selection bias or information bias.
Regulatory Acceptance:
Regulatory bodies like the FDA and EMA are working to establish guidelines for using RWE in regulatory decision-making.
In essence, RWD and RWE can be powerful tools for generating evidence about treatment effectiveness by using external control arms in clinical trials, but careful consideration of data quality and potential biases is essential.
Real-World Evidence - FDA
Jun 9, 2025 — Definitions. Real-world data are data relating to patient health status and/or the delivery of health care routinely co...
FDA
External Comparator Groups Derived from Real-world Data ...
Nov 14, 2022 — Background. Real-world data (RWD) from electronic health records (EHRs) and administrative claims databases are used i...
Springer
Examples of Real-World Evidence (RWE) Used in Medical ...
Real-world data (RWD) can be collected from a diverse array of sources, such as electronic health records, registries, administrat...
Market Data 
Markets 
AI
